Institutions

Bimzelx (bimekizumab-bkzx) - UCB

zimlovisertib (PF-06650833) - Pfizer

brepocitinib (PF-06700841) - Priovant Therap

Tavneos (avacopan) - Amgen

Humira (adalimumab) - AbbVie

Tremfya (guselkumab) - J&J

Kineret (anakinra) - SOBI

Cosentyx (secukinumab) - Novartis

ropsacitinib (PF-06826647) - Priovant Therap

povorcitinib (INCB54707) - Incyte

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

Spevigo (spesolimab-sbzo) - Boehringer Ingelheim

doxycycline - Generic mfg.

Rinvoq (upadacitinib) - AbbVie

Hutruo (bermekimab IV) - J&J

apremilast - Generic mfg.

AZD4721 - Aristea, Pfizer

Bisen R; Thakur L; Shivsingwale G; Gunde D; Mukta Y

Nov 5, 2024